Enzyme-mediated substrate association

There are inherent problems associated with enzyme-mediated methods, regardless of the method used. The right conditions must be met, of course, for the enzyme action to take place. Unlike fluorochromes or gold particles (two other marker compounds), enzymes need to act chemically for the assay to work. Also, the enzyme action must only represent the marker molecule. Endogenous enzyme or enzyme-like activity can create problems only realized in systems that use enzymes. Also, the use of enzymes demands more attention to detail because of the increase in sensitivity that is often obtained. The problem of unwanted reactivity is enhanced in enzyme-mediated reactions more so than in others, in part because of the additional level of sensitivity brought about by the continuous action on a substrate. 

The most recent application of RPLC to the analysis of enzymes has been reported by Halfpenny and Brown (HI). An assay for purine nucleoside phosphorylase, a key mediator in the purine salvage pathway, has been developed and optimal conditions for the analysis determined. Figure 20 illustrates the simultaneous separation of the substrate, inosine, and products, uric acid and hypoxanthine. In another analysis. Halfpenny and Brown (H2) developed an assay for hypoxanthine-guanine phos-phoribosyltransferase. Deficiency of this enzyme has been associated with Lesch-Nyhan syndrome as well as primary gout. The activity of the enzyme is determined by measurement of the decrease of the substrate, hypoxanthine, and increase in the product, inosine-5 -monophosphoric acid. A major advantage of using HPLC for enzyme assays is that the simultaneous measurement of both substrate and product reduces the error due to interference from competing enzymes. 

Structural information about the oxygenases provided limited insight into the mechanism (Schmidt et al. 2006). The crystallized enzyme from Synechocystis sp. PCC6803 is membrane associated and the interaction with the membrane is believed to be mediated by a nonpolar patch on the surface of the enzyme. This hydrophobic patch is thought to provide the necessary access of the protein to the membrane-bound carotenoids. Following withdrawal from the membrane, the substrate moves through the hydrophobic tunnel toward the metal center. The substrate orients the... 

The enzymatic activity in soil is mainly of microbial origin, being derived from intracellular, cell-associated or free enzymes. Only enzymatic activity of ecto-enzymes and free enzymes is used for determination of the diversity of enzyme patterns in soil extracts. Enzymes are the direct mediators for biological catabolism of soil organic and mineral components. Thus, these catalysts provide a meaningful assessment of reaction rates for important soil processes. Enzyme activities can be measured as in situ substrate transformation rates or as potential rates if the focus is more qualitative. Enzyme activities are usually determined by a dye reaction followed by a spectrophotometric measurement. 

Classical bacterial exotoxins, such as diphtheria toxin, cholera toxin, clostridial neurotoxins, and the anthrax toxins are enzymes that modify their substrates within the cytosol of mammalian cells. To reach the cytosol, these toxins must first bind to different cell-surface receptors and become subsequently internalized by the cells. To this end, many bacterial exotoxins contain two functionally different domains. The binding (B-) domain binds to a cellular receptor and mediates uptake of the enzymatically active (A-) domain into the cytosol, where the A-domain modifies its specific substrate (see Figure 1). Thus, three important properties characterize the mode of action for any AB-type toxin selectivity, specificity, and potency. Because of their selectivity toward certain cell types and their specificity for cellular substrate molecules, most of the individual exotoxins are associated with a distinct disease. Because of their enzymatic nature, placement of very few A-domain molecules in the cytosol will normally cause a cytopathic effect. Therefore, bacterial AB-type exotoxins which include the potent neurotoxins from Clostridium tetani and C. botulinum are the most toxic substances known today. However, the individual AB-type toxins can greatly vary in terms of subunit composition and enzyme activity (see Table 2). 

ATP 4- protein r <1, 2, 4, 5> (<5> microtubule-associated protein, enzyme can also phosphorylate human tau [1] <1> phosphorylates r and forms paired helical filament epitopes, r/Kl, K2, K3 and t/4 repeat [6] <2> enzyme can also phosphorylate bovine tau [4] <2> phosphorylates r protein into Alzheimer disease-like forms, resulting in neuronal death [7] <2> 6 isoforms of human r expressed in adult human brain [12] <2> when a / -mediated aggregated r is used as a substrate for TPKII, an 8fold increase in the rate of TPKII-mediated r phosphorylation is observed... 

Substrates bind to P-gp while they are associated with the plasma membrane this process is possibly the most important aspect of P-gp-mediated efflux activity to appreciate. By using fluorescent dye esters, it was shown that P-gp interacts with its substrates within the plasma membrane. As these dye esters cross the membranes, esterases quickly hydrolyze the esters to their free acid form in the cytoplasm. Cells expressing P-gp showed no accumulation of the free acid dye in the cytoplasm clearly illustrating that P-gp can efflux substrates directly from the membrane (129). Additionally, P-gp can bind to substrates at the inner leaflet—cytosolic interface as demonstrated in studies with the P-gp substrate rhodamine 123 (133). It was shown that P-gp does not influence drug concentration in the exofacial leaflet (134), thus implying that P-gp only binds compounds from either within the inner leaflet or at the inner leaflet—cytosolic interface. These findings clearly show that the behavior of the substrate/inhibitor within the lipid barrier is likely to be a primary determinant of P-gp-mediated efflux activity. This separates P-gp from traditional transporters in which binding of the substrate to the active site in an enzyme-like fashion is the primary determinant of transport activity. 

Another AT2 pathway linked to apoptosis leads to a stimulation of a soluble protein tyrosine phosphatase, SHP-1, an enzyme that associates with insulin receptor substrate (IRS)-2 (Cui et al. 2002). Overexpression of a dominant negative form of SHP-1 in PC12W cells has been found to attenuate AT2 receptor-mediated inhibition of insulin signaling. Since insulin activates Akt, it is interesting that the mechanism of apoptosis in the angiotensin II-treated PC12W cell involves the dephosphorylation and inactivation of Akt. In NIE-115 neuroblastoma cells,... 

---